4,5-diarylisoxazole HSP90 chaperone inhibitors: Potential therapeutic agents for the treatment of cancer

被引：382

作者：

Brough, Paul A. ^{[1
]}

Aherne, Wynne ^{[2
]}

Barril, Xavier ^{[1
]}

Borgognoni, Jenifer ^{[1
]}

Boxall, Kathy ^{[2
]}

Cansfield, Julie E. ^{[1
]}

Cheung, Kwai-Miny J. ^{[2
]}

Collins, Ian ^{[2
]}

Davies, Nicholas G. M. ^{[1
]}

Drysdale, Martin J. ^{[1
]}

Dymock, Brian ^{[1
]}

Eccles, Suzanne A. ^{[2
]}

Finch, Harry ^{[1
]}

Fink, Alexandra ^{[1
]}

Hayes, Angela ^{[2
]}

Howes, Robert

Hubbard, Roderick E. ^{[1
]}

James, Karen ^{[2
]}

Jordan, Allan M. ^{[1
]}

Lockie, Andrea ^{[1
]}

Martins, Vanessa ^{[2
]}

Massey, Andrew ^{[1
]}

Matthews, Thomas P. ^{[2
]}

McDonald, Edward ^{[2
]}

Northfield, Christopher J. ^{[1
]}

Pearl, Laurence H. ^{[2
]}

Prodromou, Chrisostomos ^{[2
]}

Ray, Stuart ^{[1
]}

Raynaud, Florence I. ^{[2
]}

Roughley, Stephen D. ^{[1
]}

Sharp, Swee Y. ^{[2
]}

Surgenor, Allan ^{[1
]}

Walmsley, D. Lee ^{[1
]}

Webb, Paul ^{[1
]}

Wood, Mike ^{[1
]}

Workman, Paul ^{[2
]}

Wrightt, Lisa ^{[1
]}

机构：

[1] Vernalis Ltd, Cambridge CB21 6GB, England

[2] Inst Canc Res, Canc Res UK Ctr Canc Therapeut, Sutton SM2 5NG, Surrey, England

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2008年 / 51卷 / 02期

关键词：

D O I：

10.1021/jm701018h

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Inhibitors of the Hsp90 molecular chaperone are showing considerable promise as potential chemotherapeutic agents for cancer. Here, we describe the structure-based design, synthesis, structure-activity relationships and pharmacokinetics of potent small-molecule inhibitors of Hsp90 based on the 4,5-diarylisoxazole scaffold. Analogues from this series have high affinity for Hsp90, as measured in a fluorescence polarization (FP) competitive binding assay, and are active in cancer cell lines where they inhibit proliferation and exhibit a characteristic profile of depletion of oncogenic proteins and concomitant elevation of Hsp72. Compound 40f (VER-52296/NVP-AUY922) is potent in the Hsp90 FP binding assay (IC50 = 21 nM) and inhibits proliferation of various human cancer cell lines in vitro, with GI(50) averaging 9 nM. Compound 40f is retained in tumors in vivo when administered i.p., as evaluated by cassette dosing in tumor-bearing mice. In a human colon cancer xenograft model, 40f inhibits tumor growth by similar to 50%.

引用

页码：196 / 218

页数：23

共 55 条

[1] Phase I pharmacokinetic and pharmacodynarnic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignancies [J].

Banerji, U ;

O'Donnell, A ;

Scurr, M ;

Pacey, S ;

Stapleton, S ;

Asad, Y ;

Simmons, L ;

Maloney, A ;

Raynaud, F ;

Campbell, M ;

Walton, M ;

Lakhani, S ;

Kaye, S ;

Workman, P ;

Judson, I .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (18) :4152-4161

[2] 4-amino derivatives of the Hsp90 inhibitor CCT018159 [J].

Barril, X ;

Beswick, MC ;

Collier, A ;

Drysdale, MJ ;

Dymock, BW ;

Fink, A ;

Grant, K ;

Howes, R ;

Jordan, AM ;

Massey, A ;

Surgenor, A ;

Wayne, J ;

Workman, P ;

Wright, L .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (09) :2543-2548

[3] Orally active purine-based inhibitors of the heat shock protein 90 [J].

Biamonte, MA ;

Shi, JD ;

Hong, K ;

Hurst, DC ;

Zhang, L ;

Fan, JH ;

Busch, DJ ;

Karjian, PL ;

Maldonado, AA ;

Sensintaffar, JL ;

Yang, YC ;

Kamal, A ;

Lough, RE ;

Lundgren, K ;

Burrows, FJ ;

Timony, GA ;

Boehm, MF ;

Kasibhatla, SR .

JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (02) :817-828

[4] 3-(5-chloro-2,4-dihydroxyphenyl)-pyrazole-4-carboxamides as inhibitors of the Hsp90 molecular chaperone [J].

Brough, PA ;

Barril, X ;

Beswick, M ;

Dymock, BW ;

Drysdale, MJ ;

Wright, L ;

Grant, K ;

Massey, A ;

Surgenor, A ;

Workman, P .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (23) :5197-5201

[5]

Carpino LA, 2002, ANGEW CHEM INT EDIT, V41, P442

[6] The identification, synthesis, protein crystal structure and in vitro biochemical evaluation of a new 3,4-diarylpyrazole class of Hsp90 inhibitors [J].

Cheung, KMJ ;

Matthews, TP ;

James, K ;

Rowlands, MG ;

Boxall, KJ ;

Sharp, SY ;

Maloney, A ;

Roe, SM ;

Prodromou, C ;

Pearl, LH ;

Aherne, GW ;

McDonald, E ;

Workman, P .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (14) :3338-3343

[7] Hsp90: the vulnerable chaperone [J].

Chiosis, G ;

Vilenchik, M ;

Kim, J ;

Solit, D .

DRUG DISCOVERY TODAY, 2004, 9 (20) :881-888

[8] Discovery and development of purine-scaffold Hsp90 inhibitors [J].

Chiosis, Gabriela .

CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2006, 6 (11) :1183-1191

[9]

Chiosis G, 2006, CURR OPIN INVEST DR, V7, P534

[10] GELDANAMYCIN, A NEW ANTIBIOTIC [J].

DEBOER, C ;

MEULMAN, PA ;

WNUK, RJ ;

PETERSON, DH .

JOURNAL OF ANTIBIOTICS, 1970, 23 (09) :442-&

← 1 2 3 4 5 6 →